Browse EX-10 agreements

Execution Version CREDIT AGREEMENT dated as of May 29, 2026 among IE US HARDWARE 3 LLC, as the Company, THE LENDERS PARTY HERETO, CSC DELAWARE TRUST COMPANY, as Administrative Agent, and GOLDMAN SACHS BANK USA, and JPMORGAN CHASE BANK, N.A. as Joint Lead Arrangers and Joint Bookrunners Certain confidential information contained in this document, marked by [***], has been omitted because it is both not material and is the type that IREN Limited treats as private or confidential Exhibit 10.35 ii TABLE OF CONTENTS ARTICLE I DEFINITIONS Section 1.01. Defined Terms ........................................................................................................ 1 Section 1.02. Interpretative Provision ......................................................................................... 18 Section 1.03. Rates ...................................................................................................................... 19 ARTICLE II THE CREDITS Section 2.01. Commitments ........................................................................................................ 19 Section 2.02. Loans and Borrowings .......................................................................................... 19 Section 2.03. Requests for Borrowings ....................................................................................... 20 Section 2.04. Funding of Borrowings ......................................................................................... 20 Section 2.05. [Reserved]

…

Certain confidential information contained in this document, marked by [***], has been omitted because IREN Limited (the “Company”) has determined that the information (i) is not material and/or (ii) contains personal information Non-Cancellable Non-Returnable (NCNR) and Supplemental Terms Agreement This Non-Cancellable Non-Returnable and Supplemental Terms Purchase Agreement between IE US Hardware 4 Inc. (“Customer”) and Dell Marketing L.P. (“Dell” or “Supplier”) (“NCNR Agreement”) is effective as of the date of the last signature below (“Effective Date”) and confirms and sets out certain supplementary terms and conditions that will apply to the purchase and use of the products and services set out in the purchase order CHD_NV_DELL_B200_051526, including the related quote(s) attached hereto as Exhibit 1 and/or any related updated, revised or replacement quotes, proposals or purchase orders as agreed between the parties in writing (the “Order”). Capitalized terms used but not defined in this NCNR Agreement have the meaning given to them in the Supply Contract (as defined below). 1. By signing this NCNR Agreement, Customer is expressly accepting the conditions set forth herein and the parties agree that (a) this NCNR Agreement shall constitute terms of the Order for the purposes of clause 2.5A of the CTS (as defined below) and (b) they wish to deviate from the terms of the CTS for the purposes of the Order and the parties expressly accept this deviation. The Order is designated as non-cancelable, non-returnable (“NC/NR”) and may not be cancelled, rescheduled, or

…

Certain confidential information contained in this document, marked by [***], has been omitted because IREN Limited (the “Company”) has determined that the information (i) is not material and/or (ii) contains personal information Private & Confidential May 19, 2026 IE US Hardware 4 Inc. 620 FM 1033 Childress, TX 79201 USA Attention: William Roberts and Denis Skrinnikoff Dear William and Denis: Re: Purchase Agreement between IE US Hardware 4 Inc. and Dell Marketing L.P. (USA) (Non-Financed) This purchase agreement between IE US Hardware 4 Inc. (“Customer”) and Dell Marketing L.P.(“Dell”) sets out the terms and conditions upon which Customer will purchase and/or use Products, Third Party Products (if applicable) and Services from Dell (“Purchase Agreement”). 1) Customer and Dell (collectively, the “Parties”, and each a “Party”) have agreed to use and adopt the Commercial Terms of Sale, attached hereto as Exhibit “A” (the “CTS”) as the basis of an evergreen commercial agreement between the Parties, as amended and modified below. 2) Unless otherwise defined in this Purchase Agreement, all capitalized terms used herein will have the meanings ascribed to them in the CTS. 3) Notwithstanding anything to the contrary contained in the CTS (and as contemplated by clause 2.5 of the CTS), the Parties desire to deviate from the terms of the CTS and hereby agree to the following amendments to the CTS: A. For the purposes of the CTS and this Purchase Agreement, references to the “Customer” shall be references to IE US Hardware 4 Inc.. B. Clause 1.1 is hereby deleted in its entirety

…

WORKSPORT LTD.

2500 N America Dr.

West Seneca, New York 14224

** **

August 27, 2026

Holder of Worksport December 2025 Warrants

Re:	Inducement Offer to Exercise Common Stock Purchase Warrants

Dear Holder:

Worksport Ltd. (the “Company”) is pleased to offer to you (“Holder”, “you” or similar terminology) the opportunity to receive new warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) in consideration for you exercising (i) all of the Common Stock purchase warrants issued by the Company to the Holder on December 12, 2025 (the “Existing Warrants”) at the Reduced Exercise Price (as defined below), as set forth on the signature page hereto.

The shares of Common Stock underlying the Existing Warrants (the “Warrant Shares”) have been registered pursuant to an effective registration statement on Form S-3 (File No. 333-292823), which will remain available for the issuance of the underlying shares upon exercise of Existing Warrants pursuant to this letter agreement. Capitalized terms not otherwise defined herein shall have the meanings set forth in the New Warrants (as defined herein).

…

Exhibit 10.1

2006 Route 130 North, Burlington, NJ 08016

Phone: (609) 387-7800 Fax: (609) 239-9675

PERSONAL AND CONFIDENTIAL

July 28, 2026

Via Electronic Mail

Matthew Pasch

Dear Matt:

This letter sets forth the proposal of Burlington Coat Factory Warehouse Corporation (the “Company”) regarding your separation from employment with the Company. Upon your acceptance of the terms and conditions set forth in this Letter Agreement (the “Letter Agreement”) and the General Release attached hereto as Exhibit A (the “Release”), the Company agrees to provide you with the severance package set forth in this Letter Agreement on the conditions described herein. For the purposes of this Letter Agreement, reference to the Company shall also include reference to any or all of Burlington Coat Factory Warehouse Corporation or Burlington Stores, Inc., wherever appropriate or as their interests may appear. Terms referenced but not defined herein shall have the meaning set forth in the Burlington Stores, Inc. Executive Severance Plan (amended and restated, effective March 17, 2026) (the “Severance Plan”).

1.

Last Date of Employment:

(a)

…

** Exhibit 10.1**

SUBORDINATED NOTE PURCHASE AGREEMENT

7.00% FIXED-TO-FLOATING RATE SUBORDINATED NOTE DUE 2036

This SUBORDINATED NOTE PURCHASE AGREEMENT (this “Agreement”) is dated as of August 26, 2026, and is made by and among Avidbank Holdings, Inc., a California corporation (the “Company”), and the several purchasers of the Subordinated Notes (as defined herein) identified on the signature pages hereto (each a “Purchaser” and collectively, the “Purchasers”).

RECITALS

**WHEREAS, **the Company has requested that the Purchasers purchase from the Company up to $30,000,000 in aggregate principal amount of Subordinated Notes, which aggregate amount is intended to qualify for inclusion as Tier 2 Capital (as defined herein);

**WHEREAS, **the Company has engaged Piper Sandler & Co., as its exclusive placement agent (“Placement Agent”) for the offering of the Subordinated Notes;

**WHEREAS, **each of the Purchasers is an institutional “accredited investor” as such term is defined in Rule 501(a)(1), (2), (3) or (7) of Regulation D (“Regulation D”) promulgated under the Securities Act of 1933, as amended (the “Securities Act”) or a QIB (as defined herein);

**WHEREAS, **the offer and sale of the Subordinated Notes by the Company is being made in reliance upon exemptions from registration available under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D; and

…

​

BOOT BARN HOLDINGS, INC.

2026 EQUITY INCENTIVE PLAN

​

1

---

TABLE OF CONTENTS

​

	​ ​ ​		Page
1.		Effectiveness and Purpose	3
2.		Definitions	3
3.		Administration	6
4.		Awards	7
5.		Shares Subject to the Plan.	7
6.		Eligibility for Participation	8
7.		Options	9
8.		Stock Awards	10
9.		Stock Units	10
10.		Stock Appreciation Rights	11
11.		Other Stock-Based Awards	12
12.		Dividend Equivalents	12
13.		Consequences of a Change in Control	12
14.		Deferrals	13
15.		Withholding of Taxes	13
16.		Transferability of Awards	13
17.		Requirements for Issuance or Transfer of Shares	13

…

August 27, 2026

Lawrence A. Kenyon

Dear Larry:

In accordance with the Amended and Restated Executive Employment Agreement, dated as of June 2, 2022 (“Employment Agreement”), entered into between you and Outlook Therapeutics, Inc. (the “Company”), this letter sets out the substance of the separation agreement (the “Agreement”) that the Company is offering you to aid in your employment transition. Any capitalized terms in this Separation Agreement will take their meaning from the Employment Agreement unless otherwise defined herein.

1. Transition; Separation. Effective September 1, 2026 (the “Transition Date”), you will cease serving as the Company’s Chief Financial Officer, Treasurer and Corporate Secretary and from any and all other positions held with the Company or any of the Company’s direct or indirect subsidiaries. From the Transition Date through September 30, 2026 (the “Planned Separation Date” and such period, the “Transition Period”), you will continue to be employed on an at-will basis in a non-executive employee role. During the Transition Period, you will work cooperatively with the Company to transition your various roles, duties, and responsibilities to designated personnel, and you will continue to receive the same base salary and employee benefits in effect as of the date hereof. The earlier of the Planned Separation Date and your actual last day of work with the Company will be the “Separation Date” for purposes of this Agreement. Your separation from employment with the Company is deemed a “separation from service,” as defined under the Treasury

…

EXECUTIVE EMPLOYMENT AGREEMENT

This Executive Employment Agreement (this “Agreement”) effective as of September 1, 2026 (“Effective Date”) is entered into between Outlook Therapeutics, Inc., a Delaware corporation with its principal place of business at 111 S. Wood, Avenue, Unit #100, Iselin, New Jersey 08830 (the “Company”) and Kevin Lundquist, residing at [intentionally redacted](the “Executive”).

In consideration of the promises and the terms and conditions set forth in this Agreement, the parties agree as follows:

1.              Position and Duties. As of the Effective Date, the Company will employ Executive as the Chief Financial Officer (“CFO”). Executive will report to the Company’s Chief Executive Officer (the “CEO”) and will render such business and professional services in the performance of his duties, consistent with Executive’s position, as specified in the job description attached hereto as Exhibit A and as shall reasonably be assigned to him by the CEO. The Executive shall make such business trips to such places as may be necessary or advisable for the efficient operations of the Company.

…

THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

** **

PROMISSORY NOTE

** **

Principal Amount: US$500,000

Dated: August 25, 2026

New York, New York

FOR VALUE RECEIVED, Charlton Aria Acquisition Corporation (the “Maker” or the “Company”) promises to pay to the order of ST Sponsor II Limited, or its assignees or successors in interest (the “Payee”), the principal sum of up to US$500,000 [FIVE HUNDRED THOUSAND U.S. DOLLARS] (the “Outstanding Principal Balance”), evidencing such working capital loans (the “Loans”) provided from time to time by the Payee, on the terms and conditions described below. The Loans may be drawn against this note (the “Note”) at such time and in such amount, subject to the Cap, at the request of the Company. Loans may be advanced by the Payee by wire transfer of immediately available funds to an account designated by the Company or, with the written consent of the Company, by direct payment to third-party vendors or creditors on behalf of the Company, or by such other means as the parties may agree in writing. The Payee and the Company shall maintain records of all such advances, including the amount, date, and manner of each

…

ULTA BEAUTY, INC.

2026 INCENTIVE AWARD PLAN

OPTION AGREEMENT - CERTIFICATE

The following (this “Award Agreement”) evidences the grant of an option (the “Option”) to purchase Shares of Ulta Beauty, Inc. (the “Company”) pursuant to the Ulta Beauty, Inc. 2026 Incentive Award Plan (the “Plan”) to the following individual (the “Optionee”) and upon the following terms:  

Optionee:	Name**: Address: **​Location-
Grant Date:	​
Exercise Price Per Share:	​
Total Number of Options Granted:	​
Type of Option:	​

If designated as an Incentive Stock Option, this Option is intended to qualify as an Incentive Stock Option as defined in Section 422 of the Code; provided, however, that to the extent that it does not so qualify that portion which does not so qualify shall be treated as a Non-Qualified Stock Option.

Unless otherwise defined herein, capitalized terms used in this Award Agreement shall have the same meanings as set forth in the Plan.

…

ULTA BEAUTY, INC.

2026 INCENTIVE AWARD PLAN

RESTRICTED STOCK UNIT AWARD AGREEMENT

Ulta Beauty, Inc. (the “Company”), pursuant to the Ulta Beauty, Inc. 2026 Incentive Award Plan (the “Plan”), hereby grants the number of Restricted Stock Units (each, an “RSU”) set forth below to the following individual (the “Holder”), subject to the restrictions on transfer and forfeiture and such other limitations set forth herein and in the Plan. Each RSU entitles the Holder to receive an equal number of Shares at settlement, as described herein.

**Name:**​	**Address:**​
**Grant Date **	​
Total Number of RSUs Granted	​

Unless otherwise defined herein, capitalized terms used in this agreement (this “Award Agreement”) shall have the same meanings set forth in the Plan.

1.Vesting Schedule.  The RSUs are subject to the restrictions on transfer set forth in Section 2 and may be forfeited as provided in Section 4 until vested. Once vested, the RSUs shall be settled and paid on the dates and as provided in Section 5. Holder shall vest in full in the RSUs on the earliest of:

(a)[______________];

…